ARTICLE | Company News
AngioGenex, BioCheck cancer diagnostic deal
April 22, 2004 7:00 AM UTC
AngioGenex (New York, N.Y.) granted BioCheck (Foster City, Calif.) exclusive rights to develop and market cancer diagnostic and prognostic products based on AngioGenex's Id-gene technology. The compan...